List of works - Cecilia Beatrice Chighizola

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases

scientific article published on 21 December 2018

14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome

scientific article published on 17 March 2014

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

scientific article published on 10 May 2014

APS and the Nervous System

article published in 2014

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

scientific article published in July 2013

Antibodies and Diagnostic Tests in Antiphospholipid Syndrome

Antiphospholipid Antibodies and Infertility: A Gene Expression Study in Decidual Stromal Cells

scientific article published on March 2016

Antiphospholipid Antibody Mechanisms of Thrombosis

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository

scientific article published on 01 September 2020

Antiphospholipid antibodies and infertility

article

Antiphospholipid antibodies and reproductive failures

scientific article published on 29 April 2020

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

scientific article

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).

scientific article published in July 2008

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.

scientific article published on 14 February 2014

Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester

scientific article published on 11 July 2020

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome

scientific article published on 14 February 2018

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)

scientific article published on 28 July 2020

Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment

scientific article published on 05 August 2020

Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome

scientific article published in May 2015

Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: reply

scientific article published on 10 September 2020

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

scientific article published on 03 October 2019

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository

scientific article published on 08 September 2019

Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies

scientific article published on 18 December 2018

Does APS Impact Women's Fertility?

scientific article published on June 2017

EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies

scientific article published on 22 May 2020

Editorial: New Therapies in the Field of Rheumatology

scientific article published on 01 January 2019

Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature

scientific article

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts

scientific article published on 29 August 2018

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

scientific article published on 05 April 2013

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

scientific article published on 30 March 2020

Introduction

scientific article published on 01 March 2011

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature

scientific article

Lung Disease in Antiphospholipid Syndrome

scientific article published on 01 April 2019

Management of Thrombotic Antiphospholipid Syndrome.

scientific article published on 9 March 2017

N-TproBNP as biomarker in systemic sclerosis.

scientific article published on December 2012

N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis

scientific article published on 7 April 2016

New Treatments

New oral anticoagulants in thrombotic antiphospholipid syndrome.

scientific article published in October 2014

New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies

scientific article published on February 2014

Novel mechanisms of action of the biologicals in rheumatic diseases.

scientific article published on August 2014

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

scientific article published on 01 July 2018

Obstetric antiphospholipid syndrome: lobsters only? Or should we also look for selected red herrings?

scientific article published in February 2015

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

scientific article

Pathophysiology of the antiphospholipid syndrome (APS)

scientific article published on 23 October 2012

Phospholipid Autoantibodies (Nonanticardiolipin)-Antiprothrombin Antibodies

Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.

scientific article

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)

scientific article published on 16 September 2020

Reply

scientific article published on 01 June 2014

Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients

scientific article published on March 1, 2012

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis

scientific article published on 09 November 2020

Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?

scientific article published on 29 September 2017

Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome

scientific article published on 03 September 2020

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy

scientific article published on 27 August 2020

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

scientific article published on 15 February 2019

The Geoepidemiology of Autoimmune Liver Disease

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

scientific article published on 29 October 2020

The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review

scientific article published on 11 August 2016

The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.

scientific article

The challenges of lupus anticoagulants

scientific article

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis

scientific article published on 18 January 2019

The hidden world of anti-phospholipid antibodies and female infertility: A literature appraisal

scientific article published on 28 January 2016

The interplay between the antiphospholipid syndrome and systemic lupus erythematosus

scientific article published on May 2009

The role of environmental estrogens and autoimmunity.

scientific article published on 04 December 2011

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach

scientific article published on 12 February 2018

The use of biologics and small molecules in pregnant patients with rheumatic diseases

scientific article published on 29 September 2018

Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?

scientific article published on 28 November 2017

Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons".

scientific article published on 22 October 2011

Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment

scientific article published on 31 May 2018

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

scientific article published on 01 October 2014

Treatment of Pregnancy Complications

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches

scientific article published on 5 May 2015

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies

scientific article published on 14 August 2019

Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome

scientific article

Update on the pathogenesis and treatment of the antiphospholipid syndrome.

scientific article published on September 2015

β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.

scientific article published on 27 March 2014

List of works by Cecilia Beatrice Chighizola

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases

14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

APS and the Nervous System

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

Antibodies and Diagnostic Tests in Antiphospholipid Syndrome

Antiphospholipid Antibodies and Infertility: A Gene Expression Study in Decidual Stromal Cells

Antiphospholipid Antibody Mechanisms of Thrombosis

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository

Antiphospholipid antibodies and infertility

Antiphospholipid antibodies and reproductive failures

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.

Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)

Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment

Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome

Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: reply

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository

Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies

Does APS Impact Women's Fertility?

EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies

Editorial: New Therapies in the Field of Rheumatology

Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

Introduction

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature

Lung Disease in Antiphospholipid Syndrome

Management of Thrombotic Antiphospholipid Syndrome.

N-TproBNP as biomarker in systemic sclerosis.

N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis

New Treatments

New oral anticoagulants in thrombotic antiphospholipid syndrome.

New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies

Novel mechanisms of action of the biologicals in rheumatic diseases.

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

Obstetric antiphospholipid syndrome: lobsters only? Or should we also look for selected red herrings?

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Pathophysiology of the antiphospholipid syndrome (APS)

Phospholipid Autoantibodies (Nonanticardiolipin)-Antiprothrombin Antibodies

Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)

Reply

Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis

Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?

Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

The Geoepidemiology of Autoimmune Liver Disease

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review

The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.

The challenges of lupus anticoagulants

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis

The hidden world of anti-phospholipid antibodies and female infertility: A literature appraisal

The interplay between the antiphospholipid syndrome and systemic lupus erythematosus

The role of environmental estrogens and autoimmunity.

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach

The use of biologics and small molecules in pregnant patients with rheumatic diseases

Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?

Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons".

Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

Treatment of Pregnancy Complications

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies

Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome

Update on the pathogenesis and treatment of the antiphospholipid syndrome.

β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.